Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07AOY
|
||||
Former ID |
DNCL003528
|
||||
Drug Name |
Avarofloxacin
|
||||
Synonyms |
JNJ-Q2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bacterial pneumonia [ICD10:J13, J15] | Discontinued in Phase 2 | [549103] | ||
Company |
Furiex pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H23F2N3O4
|
||||
Canonical SMILES |
COC1=C2C(=CC(=C1N3CCCC(=C(CN)F)C3)F)C(=O)C(=CN2C4CC4)C(<br />=O)O
|
||||
InChI |
1S/C21H23F2N3O4/c1-30-20-17-13(19(27)14(21(28)29)10-26(17)12-4-5-12)7-15(22)18(20)25-6-2-3-11(9-25)16(23)8-24/h7,10,12H,2-6,8-9,24H2,1H3,(H,28,29)/b16-11+
|
||||
InChIKey |
VMKVDAAFMQKZJS-LFIBNONCSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Topoisomerase IV | Target Info | Modulator | [531620] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.